BRG.AU

29.24

-0.54%↓

BRG.AU

29.24

-0.54%↓

BRG.AU

29.24

-0.54%↓

BRG.AU

29.24

-0.54%↓

BRG.AU

29.24

-0.54%↓

Search

Fisher & Paykel Healthcare Corp Ltd

Fermé

SecteurImmobilier

34.06 -1.67

Résumé

Variation du prix de l'action

24h

Actuel

Min

33.82

Max

34.19

Chiffres clés

By Trading Economics

Revenu

224M

377M

Ventes

951M

P/E

Moyenne du Secteur

122.393

58.795

BPA

0.26

Rendement du dividende

1.12

Marge bénéficiaire

39.655

Employés

7,384

EBITDA

276M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+10.46% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

1.12%

5.68%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-881M

20B

Ouverture précédente

35.73

Clôture précédente

34.06

Sentiment de l'Actualité

By Acuity

38%

62%

50 / 190 Classement par Real estate

Fisher & Paykel Healthcare Corp Ltd Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

28 mai 2025, 22:28 UTC

Market Talk

Fisher & Paykel Healthcare's Progress Attracts New Bull -- Market Talk

8 avr. 2025, 02:01 UTC

Market Talk

Tariff Impact on Fisher & Paykel Less Than Expected -- Market Talk

3 févr. 2025, 21:55 UTC

Market Talk

F&P Healthcare Could Make More in New Zealand to Counter Tariff Impact -- Market Talk

2 févr. 2025, 22:06 UTC

Market Talk

Fisher & Paykel Healthcare Slumps on Tariff Hit -- Market Talk

28 nov. 2024, 21:55 UTC

Market Talk

F&P Healthcare Bear Sees Limited Scope for Guidance Upgrades -- Market Talk

18 nov. 2024, 22:39 UTC

Market Talk

Sales Growth, Flu Season in Focus at F&P Healthcare's 1H Result -- Market Talk

2 sept. 2024, 23:56 UTC

Market Talk

Fisher & Paykel's Growth Outlook Looks Attractive -- Market Talk

Comparaison

Variation de prix

Fisher & Paykel Healthcare Corp Ltd prévision

Objectif de Prix

By TipRanks

10.46% hausse

Prévisions sur 12 Mois

Moyen 38.351 AUD  10.46%

Haut 42.1 AUD

Bas 35.9 AUD

Basé sur 9 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

9 ratings

5

Achat

4

Maintien

0

Vente

Sentiment

By Acuity

50 / 190Classement par Immobilier

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.